ClinicalTrials.gg
RecruitingNCT07130929RISEUpdated Dec 11, 2025

Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study.

An interventional study of Functional Electrical Stimulation and Conventional physiotherapy in Intensive Care Unit (ICU) Acquired Weakness (ICU - AW) and Acquired Brain Injury (Including Stroke), sponsored by Fondazione Don Carlo Gnocchi ETS. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-11.

Sponsored by Fondazione Don Carlo Gnocchi ETS · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 76 studies in Brain Injuries with a site in Italy — 27 open to participants now, 29 under way, none of them phase 3. Brain Injuries · Italy.

Planned enrollment
31st of 48
24 · median 40
Started
2025
with 7 others
No phase
43 of 76
14 open now
Primary completion
2026-09
later than 13 of 28 live
Registered
67th of 76
by date
Lead sponsor
2 of 76
Fondazione Don Carlo Gnocchi ETS

Among the 76 studies in Brain Injuries with a site in Italy, this one is the 31st largest by planned enrollment of the 48 interventional ones that give a count, is one of 8 that started in 2025, is one of 43 with no phase, reaches primary completion later than 13 of the 28 other live ones, and was the 67th registered.

Brain Injuries

947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.

Browse Brain Injuries studies →

Open to participants now

27 of the 76 studies in Brain Injuries with a site in Italy are open now. Recruiting first, the newest first:

21 more — sign in →

All 27 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Brain Injuries with a site in Italy, or all of them as a file.
02

Study summary

This study aims to evaluate the effectiveness of physiotherapy treatment combined with functional electrical stimulation (FES) in a small group of patients with severe acquired brain injury (SABI) of vascular origin and with a clinical and instrumental diagnosis of "Intensive Care Unit-Acquired Weakness" (ICU-AW). Functional electrical stimulation is a technology that uses electrical impulses, generated by an external device, to reactivate the neuromuscular system through electrodes applied to the skin. In functional electrical stimulation, this process is integrated into physiotherapy sessions, with the active involvement of the patient, through the performance of exercises with the assistance and supervision of the physiotherapist. The rationale behind this is to stimulate neuroplasticity processes by facilitating movement through the application of electrical stimuli and the active participation of the patient in performing a motor task, in an attempt to promote improvement in an impaired function.

In particular, the objectives that will be pursued are: improvement of lower limb neuromyopathy assessed clinically using the Medical Research Council (MRC) scale, the Fugl-Meyer scale for lower limbs, the Short Physical Performance Battery (SPPB) scale, the assessment of active and passive Range Of Motion (ROM) of the main joints of the lower limb (hip, knee, ankle) and measured instrumentally by neurophysiological examination and ultrasound examination.

After randomization, patients in the control arm will be treated with physiotherapy and speech therapy sessions as per the conventional protocol, and an additional 15 physiotherapy sessions lasting 60 minutes over a period of 5 weeks. Alternatively, patients in the experimental group will receive, in addition to conventional rehabilitation treatment, a treatment consisting of 15 physiotherapy sessions combined with FES lasting 60 minutes over a period of 5 weeks.

At the end of the treatment period, baseline characteristics and clinical and instrumental outcome variables will be compared between the two groups using the chi-square test for dichotomous and categorical variables and the t-test for independent samples or the Mann-Whitney U test for continuous variables, depending on whether or not they are normally distributed. In all analyses, a p-value \<0.05 will be considered significant.

03

Conditions studied

  • Intensive Care Unit (ICU) Acquired Weakness (ICU - AW)
  • Acquired Brain Injury (Including Stroke)

Keywords

  • stroke
  • Intensive Care Unit (ICU) acquired weakness (ICU - AW)
  • Functional Electrical Stimulation
  • FES
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of ischemic or hemorrhagic vascular GCA involving unilateral motor deficit \< 3 months;
  • Premorbid Modified Rankin Scale \<2;
  • Age >18 years and \<80 years;
  • Level of Cognitive Functioning > 4 for active participation in treatment.
  • MRC total sum score \<= 48 (range 0 -60) for clinical suspicion of ICU-AW
  • Clinical diagnosis of tetra/paraparesis of peripheral origin confirmed by neurophysiological examination;
  • Signature of by the patient or, if incapacitated, by their legal representative.

Exclusion criteria

Exclusion Criteria:

  • Clinical cardio-respiratory or internal instability such as to prevent treatment;
  • History of previous comorbidity for ICU-AW;
  • Previous known chronic neuropathy;
  • Severe coagulopathy;
  • Skin integrity problems at the interface surfaces with the electrostimulator;
  • Epilepsy not controlled by medication;
  • Presence of implanted electronic devices;
  • Pregnancy or breastfeeding;
  • Severe spasticity with a score of >3 on the modified Ashworth scale;
  • Treatment with botulinum toxin;
  • Recent malignant neoplasm;
  • Conditions that put you at risk for neuropathies, e.g., history of diabetes mellitus, renal failure, hepatic failure, vitamin deficiencies, chronic alcoholism, vasculitis, previous use of neurotoxic drugs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Arm in treatment with conventional physiotherapy plus FES

    Other: Functional Electrical Stimulation

  • Active comparator
    Arm in treatment with only conventional physiotherapy

    conventional physiotherapy in an equivalent additional session (without FES).

    Other: Conventional physiotherapy

Interventions

  • OtherFunctional Electrical Stimulation

    Physiotherapy exercises, selected from a group of active flexion-extension exercises, cycle ergometer, sit-to-stand exercises and a preparatory exercise for the gait pattern with hip flexion and subsequent loading on the lower limb, associated with functional electrical stimulation.

  • OtherConventional physiotherapy

    Conventional physiotherapy exercises, selected from a group of active flexion-extension exercises, cycle ergometer, sit-to-stand exercises and a preparatory exercise for the gait pattern with hip flexion and subsequent loading on the lower limb.

06

What researchers measure

Primary outcomes

  1. Change in lower limb neuromyopathy assessed blindly compared to the treatment/control arm at the clinical level using the Medical Research Council (MRC) scale.

    Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).

Secondary outcomes

  1. Change in the units of the scale "Fugl-Meyer scale for lower limbs".

    Time frame: From enrollment to the end of treatment at 5 weeks (T1) and from enrollment to the follow-up at 12 weeks(T2).

  2. Change in the units of the scale "the Short Physical Performance Battery (SPPB) scale".

    Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).

  3. Change in the degrees of the active range of motion of the main joints of the lower limbs (hip, knee, ankle).

    Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).

  4. Change in the degrees of passive range of motion of the main joints of the lower limbs (hip, knee, ankle).

    Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).

  5. Change in the parameters recorded during the neurophysiological examination using electromyography.

    Time frame: From enrollment to the end of treatment at 5 weeks (T1).

  6. Change in the parameters recorded during ultrasound examination

    Change in the parameters recorded during ultrasound examination of the transverse diameter of the rectus femoris.

    Time frame: From enrollment to the end of treatment at 5 weeks (T1).

  7. Change in the parameters recorded during ultrasound examination

    Change in the difference between the distance from the skin plane and the deep layer of the rectus femoris recorded with the muscle at rest and during contraction, recorded using M-mode ultrasound.

    Time frame: From enrollment to the end of treatment at 5 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Wong JN, Olson JL, Morhart MJ, Chan KM. Electrical stimulation enhances sensory recovery: a randomized controlled trial. Ann Neurol. 2015 Jun;77(6):996-1006. doi: 10.1002/ana.24397. Epub 2015 May 4. PubMed 25727139 ↗
  • Cecatto RB, Maximino JR, Chadi G. Motor recovery and cortical plasticity after functional electrical stimulation in a rat model of focal stroke. Am J Phys Med Rehabil. 2014 Sep;93(9):791-800. doi: 10.1097/PHM.0000000000000104. PubMed 24800715 ↗
  • Peckham PH, Knutson JS. Functional electrical stimulation for neuromuscular applications. Annu Rev Biomed Eng. 2005;7:327-60. doi: 10.1146/annurev.bioeng.6.040803.140103. PubMed 16004574 ↗
  • Intiso D, DI Rienzo F, Fontana A, Tolfa M, Bartolo M, Copetti M. Functional outcome of critical illness polyneuropathy in patients affected by severe brain injury. Eur J Phys Rehabil Med. 2017 Dec;53(6):910-919. doi: 10.23736/S1973-9087.17.04595-6. Epub 2017 Apr 14. PubMed 28417610 ↗
  • Hakiki B, Draghi F, Scarpino M, Portaccio E, Romoli A, Mannini A, Atzori T, Lolli F, Macchi C, Grippo A. Critical illness polyneuromyopathy: Functional impact after severe acquired brain injuries. Acta Neurol Scand. 2020 Dec;142(6):574-584. doi: 10.1111/ane.13324. Epub 2020 Aug 31. PubMed 32740902 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.

Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 12 months is below that.

Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2025
First posted
Aug 19, 2025
StartActual
Sep 23, 2025
Primary completionEst.
Sep 23, 2026
CompletionEst.
Mar 23, 2027
Last update
Dec 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07130929
Lead sponsor
Fondazione Don Carlo Gnocchi ETS
Collaborators
University of Florence
Responsible party
Sponsor
First posted
Aug 19, 2025
Start date
Sep 23, 2025
Primary completion
Sep 23, 2026 (estimated)
Completion
Mar 23, 2027 (estimated)
Last update
Dec 11, 2025

Study contacts

Bahia Hakiki
Contact
bhakiki@dongnocchi.it
00390557393906

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion